New pill takes aim at Cancer's DNA repair
Disease control
Recruiting now
This early-stage trial tests an experimental pill called TRE-515 in people with advanced solid tumors that have not responded to standard treatments. The drug works by blocking a key enzyme cancer cells need to make DNA, potentially slowing tumor growth. The main goals are to fin…
Phase: PHASE1 • Sponsor: Trethera • Aim: Disease control
Last updated May 04, 2026 16:23 UTC